These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15042944)

  • 1. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy.
    Bukantz SC; Lockey RF
    Clin Allergy Immunol; 2004; 18():711-27. PubMed ID: 15042944
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy.
    Bukantz SC; Bagg AS; Lockey RF
    Clin Allergy Immunol; 2008; 21():455-68. PubMed ID: 18828523
    [No Abstract]   [Full Text] [Related]  

  • 3. The management of local reactions due to allergen immunotherapy.
    Taşkapan O
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):94. PubMed ID: 14756475
    [No Abstract]   [Full Text] [Related]  

  • 4. Side-effects of allergen-specific immunotherapy: a prospective multi-centre study.
    Winther L; Arnved J; Malling HJ; Nolte H; Mosbech H
    Clin Exp Allergy; 2006 Mar; 36(3):254-60. PubMed ID: 16499635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic reactions associated with subcutaneous allergen immunotherapy: timing and risk assessment.
    DaVeiga SP; Liu X; Caruso K; Golubski S; Xu M; Lang DM
    Ann Allergy Asthma Immunol; 2011 Jun; 106(6):533-537.e2. PubMed ID: 21624754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy safety: what have we learned from surveillance surveys?
    Kannan JA; Epstein TG
    Curr Allergy Asthma Rep; 2013 Aug; 13(4):381-8. PubMed ID: 23636820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus.
    Tabar AI; Echechipía S; García BE; Olaguibel JM; Lizaso MT; Gómez B; Aldunate MT; Martin S; Marcotegui F
    J Allergy Clin Immunol; 2005 Jul; 116(1):109-18. PubMed ID: 15990782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Instructions and consent forms for subcutaneous allergen immunotherapy.
    Cox L; Lockey RF
    Clin Allergy Immunol; 2008; 21():499-525. PubMed ID: 18828526
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe adverse reactions during specific subcutaneous immunotherapy.
    Ricciardi L; Isola S; Gangemi S; Cilia M; Levanti C; D'Ambrosio FP
    Allergy; 1996 Jan; 51(1):62. PubMed ID: 8721532
    [No Abstract]   [Full Text] [Related]  

  • 10. Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and Hymenoptera allergy.
    Bonadonna P; Zanotti R; Caruso B; Castellani L; Perbellini O; Colarossi S; Chilosi M; Dama A; Schiappoli M; Pizzolo G; Senna G; Passalacqua G
    J Allergy Clin Immunol; 2008 Jan; 121(1):256-7. PubMed ID: 18206512
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic reactions to allergen immunotherapy: a review of the literature.
    Nettis E; Giordano D; Ferrannini A; Tursi A
    Immunopharmacol Immunotoxicol; 2003 Feb; 25(1):1-11. PubMed ID: 12675195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaphylactic reactions during immunotherapy.
    Rezvani M; Bernstein DI
    Immunol Allergy Clin North Am; 2007 May; 27(2):295-307, viii. PubMed ID: 17493504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual immunotherapy: a comprehensive review.
    Cox LS; Larenas Linnemann D; Nolte H; Weldon D; Finegold I; Nelson HS
    J Allergy Clin Immunol; 2006 May; 117(5):1021-35. PubMed ID: 16675328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The LOCAL Study: Local reactions do not predict local reactions in allergen immunotherapy.
    Calabria CW; Coop CA; Tankersley MS
    J Allergy Clin Immunol; 2009 Oct; 124(4):739-44. PubMed ID: 19767075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
    Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
    Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of specific immunotherapy to mosquito bites.
    Ariano R; Panzani RC
    Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):131-8. PubMed ID: 15180354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The REPEAT study: recognizing and evaluating periodic local reactions in allergen immunotherapy and associated systemic reactions.
    Calabria CW; Stolfi A; Tankersley MS
    Ann Allergy Asthma Immunol; 2011 Jan; 106(1):49-53. PubMed ID: 21195945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-fatal systemic reactions to subcutaneous immunotherapy: a 20-year experience comparison of two 10-year periods.
    Ragusa VF; Massolo A
    Eur Ann Allergy Clin Immunol; 2004 Feb; 36(2):52-5. PubMed ID: 15061395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possibilities and limits of desensitization].
    Mohorn M; Wenz W
    Z Arztl Fortbild (Jena); 1981 Jun; 75(11-12):524-6. PubMed ID: 7303744
    [No Abstract]   [Full Text] [Related]  

  • 20. Lake algae as a specific allergen in respiratory allergy.
    Hosen H
    Rev Allergy; 1968 May; 22(5):477-82. PubMed ID: 5651886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.